{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:13:43Z","timestamp":1752671623616,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00431-018-3205-z","type":"journal-article","created":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T22:59:13Z","timestamp":1531695553000},"page":"1497-1503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2)"],"prefix":"10.1007","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5838-9758","authenticated-orcid":false,"given":"Mark D.","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Barrientos-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Sung","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Lunsford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3l\u00f6f","family":"Th\u00f3risd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehama","family":"Zuckerman-Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"3205_CR1","unstructured":"American Diabetes Association (2017) Standards of medical care in diabetes-2018: summary of revisions. Diabetes Care 41:S1\u2013S159"},{"key":"3205_CR2","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jama.2014.3201","volume":"311","author":"D Dabelea","year":"2014","unstructured":"Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Crume T, Liese AD, Merchant AT, Lawrence JM, Reynolds K, Dolan L, Liu LL, Hamman RF, SEARCH for Diabetes in Youth Study (2014) Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311:1778\u20131786","journal-title":"JAMA"},{"key":"3205_CR3","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2337\/dc05-2470","volume":"29","author":"MC Eppens","year":"2006","unstructured":"Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, Silink M, Donaghue KC (2006) Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29:1300\u20131306","journal-title":"Diabetes Care"},{"key":"3205_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00125-013-2915-z","volume":"56","author":"S Fazeli Farsani","year":"2013","unstructured":"Fazeli Farsani S, van der Aa MP, van der Vorst MMJ, Knibbe CAJ, de Boer A (2013) Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia 56:1471\u20131488","journal-title":"Diabetologia"},{"key":"3205_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/dom.12106","volume":"15","author":"BM Frier","year":"2013","unstructured":"Frier BM, Russell-Jones D, Heise T (2013) A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review. Diabetes Obes Metab 15:978\u2013986","journal-title":"Diabetes Obes Metab"},{"key":"3205_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1399-5448.2010.00657.x","volume":"12","author":"JAL Gemmill","year":"2011","unstructured":"Gemmill JAL, Brown RJ, Nandagopal R, Rodriguez LM, Rother KI (2011) Clinical trials in youth with type 2 diabetes. Pediatr Diabetes 12:50\u201357","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"3205_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/nyas.12939","volume":"1353","author":"TS Hannon","year":"2015","unstructured":"Hannon TS, Arslanian SA (2015) The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Ann N Y Acad Sci 1353(1):113\u2013137","journal-title":"Ann N Y Acad Sci"},{"key":"3205_CR8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2337\/dc05-1365","volume":"29","author":"K Hermansen","year":"2006","unstructured":"Hermansen K, Davies M, Derezinski T, Martinez RG, Clauson P, Home P (2006) A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care 29:1269\u20131274","journal-title":"Diabetes Care"},{"key":"3205_CR9","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2337\/dc12-0669","volume":"35","author":"G Imperatore","year":"2012","unstructured":"Imperatore G, Boyle JP, Thompson TJ, SEARCH for Diabetes in Youth Study Group et al (2012) Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 35:2515\u20132520","journal-title":"Diabetes Care"},{"key":"3205_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3\u201319","journal-title":"Diabetologia"},{"key":"3205_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pcd.2016.09.003","volume":"11","author":"K Khunti","year":"2017","unstructured":"Khunti K, Millar-Jones D (2017) Clinical inertia to insulin initiation and intensification in the UK: a focused literature review. Prim Care Diabetes 11:3\u201312","journal-title":"Prim Care Diabetes"},{"key":"3205_CR12","first-page":"1","volume":"2002","author":"RJ Kuczmarski","year":"2002","unstructured":"Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002:1\u2013190","journal-title":"Vital Health Stat 11"},{"key":"3205_CR13","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.2337\/db13-1891","volume":"63","author":"JM Lawrence","year":"2014","unstructured":"Lawrence JM, Imperatore G, Dabelea D, SEARCH for Diabetes in Youth Study Group et al (2014) Trends in incidence of type 1 diabetes among non-Hispanic white youth in the U.S., 2002\u20132009. Diabetes 63:3938\u20133945","journal-title":"Diabetes"},{"key":"3205_CR14","first-page":"277","volume":"56","author":"J Ludvigsson","year":"2004","unstructured":"Ludvigsson J (2004) Prevention of adverse events in juvenile diabetes. Minerva Pediatr 56:277\u2013290","journal-title":"Minerva Pediatr"},{"key":"3205_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","volume":"376","author":"EJ Mayer-Davis","year":"2017","unstructured":"Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, Imperatore G, Linder B, Marcovina S, Pettitt DJ, Pihoker C, Saydah S, Wagenknecht L, SEARCH for Diabetes in Youth Study (2017) Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 376:1419\u20131429","journal-title":"N Engl J Med"},{"key":"3205_CR16","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/dc16-1066","volume":"39","author":"KJ Nadeau","year":"2016","unstructured":"Nadeau KJ, Anderson BJ, Berg EG, Chiang JL, Chou H, Copeland KC, Hannon TS, Huang TTK, Lynch JL, Powell J, Sellers E, Tamborlane WV, Zeitler P (2016) Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities. Diabetes Care 39:1635\u20131642","journal-title":"Diabetes Care"},{"key":"3205_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jadohealth.2013.08.017","volume":"54","author":"TT Nguyen","year":"2014","unstructured":"Nguyen TT, Jayadeva V, Cizza G, Brown RJ, Nandagopal R, Rodriguez LM, Rother KI (2014) Challenging recruitment of youth with type 2 diabetes into clinical trials. J Adolesc Health 54:247\u2013254","journal-title":"J Adolesc Health"},{"key":"3205_CR18","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0140-6736(07)60821-6","volume":"369","author":"O Pinhas-Hamiel","year":"2007","unstructured":"Pinhas-Hamiel O, Zeitler P (2007) Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 369:1823\u20131831","journal-title":"Lancet"},{"key":"3205_CR19","first-page":"107","volume":"69","author":"T Reinehr","year":"2008","unstructured":"Reinehr T, Schober E, Roth CL, Wiegand S, Holl R, DPV-Wiss Study Group (2008) Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res 69:107\u2013113","journal-title":"Horm Res"},{"key":"3205_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/07853890.2016.1278302","volume":"49","author":"AY Strandberg","year":"2017","unstructured":"Strandberg AY, Khanfir H, M\u00e4kimattila S, Saukkonen T, Strandberg TE, Hoti F (2017) Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults. Ann Med 49:357\u2013364","journal-title":"Ann Med"},{"key":"3205_CR21","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dc13-0743","volume":"36","author":"WV Tamborlane","year":"2013","unstructured":"Tamborlane WV, Klingensmith G (2013) Crisis in care: limited treatment options for type 2 diabetes in adolescents and youth. Diabetes Care 36:1777\u20131778","journal-title":"Diabetes Care"},{"key":"3205_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/pedi.12263","volume":"16","author":"N Thalange","year":"2015","unstructured":"Thalange N, Deeb L, Iotova V, Kawamura T, Klingensmith G, Philotheou A, Silverstein J, Tumini S, Ocampo Francisco AM, Kinduryte O, Danne T (2015) Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes. Pediatr Diabetes 16:164\u2013176","journal-title":"Pediatr Diabetes"},{"key":"3205_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ijo.2009.195","volume":"34","author":"TODAY Study Group","year":"2010","unstructured":"TODAY Study Group (2010) Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study. Int J Obes 34:217\u2013226","journal-title":"Int J Obes"},{"key":"3205_CR24","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2337\/dc12-2393","volume":"36","author":"TODAY Study Group","year":"2013","unstructured":"TODAY Study Group (2013) Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY. Diabetes Care 36:1749\u20131757","journal-title":"Diabetes Care"},{"key":"3205_CR25","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","volume":"366","author":"P Zeitler","year":"2012","unstructured":"TODAY Study Group, Zeitler P, Hirst K et al (2012) A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366:2247\u20132256","journal-title":"N Engl J Med"},{"key":"3205_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1067\/mpd.2000.103504","volume":"136","author":"TK Young","year":"2000","unstructured":"Young TK, Dean HJ, Flett B, Wood-Steiman P (2000) Childhood obesity in a population at high risk for type 2 diabetes. J Pediatr 136:365\u2013369","journal-title":"J Pediatr"},{"issue":"Suppl. 20","key":"3205_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/pedi.12179","volume":"15","author":"P Zeitler","year":"2014","unstructured":"Zeitler P, Fu J, Tandon N, Nadeau K, Urakami T, Barrett T, Maahs D, International Society for Pediatric and Adolescent Diabetes (2014) Type 2 diabetes in the child and adolescent. Pediatr Diabetes 15(Suppl. 20):26\u201346","journal-title":"Pediatr Diabetes"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-018-3205-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-018-3205-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-018-3205-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T07:42:57Z","timestamp":1568965377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-018-3205-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3205"],"URL":"https:\/\/doi.org\/10.1007\/s00431-018-3205-z","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"type":"print","value":"0340-6199"},{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"22 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical statements"}},{"value":"BL and OT are employees of Novo Nordisk. The remaining authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was collected from all patients or legally acceptable representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}